Literature DB >> 12638836

Rhinocerebral mucormycosis: case report.

J F Onyango1, J K Kayima, W O Owen.   

Abstract

Rhinocerebral mucormycosis is a rare, fulminating opportunistic fungal infection caused by a fungus of the order mucorales. These fungi are ubiquitous, subsisting on decaying vegetation and diverse organic material. Although the fungi and spores of mucorales show minimal intrinsic pathogenicity towards normal persons, they can initiate aggressive and fulminating infection in the immune compromised host. Because rhinocerebral mucormycosis occurs infrequently it may pose a diagnostic and therapeutic dilemma for those who are not familiar with its clinical presentation. We present a patient with classical presentation of rhinocerebral mucormycosis involving the paranasal sinuses, the orbit and cranial base who, was treated by a combination of aggressive surgical and medical therapy and subsequently had surgical repair of the oral defect. The purpose of this presentation is to draw attention to the clinical presentation and pathogenesis of rhinocerebral mucormycosis and to emphasise the need for high index of suspicion in its diagnosis and management.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12638836     DOI: 10.4314/eamj.v79i7.8845

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  3 in total

1.  A successful treatment of rhinocerebral mucormycosis due to Rhizopus oryzae.

Authors:  Rasoul Mohammadi; Mehdi Nazeri; Sayed Mohammad Amin Sayedayn; Hassan Ehteram
Journal:  J Res Med Sci       Date:  2014-01       Impact factor: 1.852

2.  Rhinocerebral mucormycosis in a diabetes type 2 patient: A fatal case report from northern Tanzania.

Authors:  Desderius Celestine Chussi; Michael Kayuza; Marco Magwizi; Peter Shija; Adnan Sadiq; Patrick Amsi; Denis Katundu; Philbert Mtenga
Journal:  SAGE Open Med Case Rep       Date:  2022-02-21

3.  Radiological spectrum of invasive mucormycosis in COVID-19.

Authors:  Nandini Passi; Anshu C Wadhwa; Swati Naik
Journal:  BJR Case Rep       Date:  2022-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.